Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Dec;39(12):2620–2624. doi: 10.1128/aac.39.12.2620

Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?

H F Chambers 1, D Moreau 1, D Yajko 1, C Miick 1, C Wagner 1, C Hackbarth 1, S Kocagöz 1, E Rosenberg 1, W K Hadley 1, H Nikaido 1
PMCID: PMC163000  PMID: 8592990

Abstract

An increase in the number of tuberculosis cases caused by multiple-drug-resistant strains of Mycobacterium tuberculosis has stimulated search for new antituberculous agents. Beta-lactam antibiotics, traditionally regarded as ineffective against tuberculosis, merit consideration. Four major penicillin-binding proteins (PBPs) with approximate molecular sizes of 94, 82, 52, and 37 kDa were detected by fluorography of [3H]penicillin-radiolabeled membrane proteins prepared from M. tuberculosis H37Ra. The presence of membrane-associated beta-lactamase precluded the use of membranes for assaying the binding affinities of beta-lactam antibiotics. Therefore, ampicillin affinity chromatography was used to purify these four PBPs from crude membranes in order to assay the binding affinities of beta-lactam antibiotics. Ampicillin, amoxicillin, and imipenem, beta-lactam antibiotics previously reported to be active in vitro against M. tuberculosis, bound to M. tuberculosis PBPs at therapeutically achievable concentrations. Binding of the 94-, 82-, and 52-kDa PBPs, but not the 37-kDa PBP, was associated with antibacterial activity, suggesting that these PBPs are the critical targets. Studies of mycobacterial cell wall permeability, which was assayed with a panel of reference cephalosporins and penicillins with different charge positivities, indicated that the rate of penetration of beta-lactam antibiotics to the target PBPs could not account for resistance. Resistance could be reversed with the beta-lactamase inhibitors clavulanate or sulbactam or could be circumvented by the use of a beta-lactamase-stable drug, imipenem, indicating that mycobacterial beta-lactamase, probably in conjunction with slow penetration, is a major determinant of M. tuberculosis resistance to beta-lactam antibiotics. These findings confirm in vitro data that M. tuberculosis is susceptible to some beta-lactam antibiotics. Further evaluation of these drugs for the treatment of tuberculosis in animal models and in clinical trials is warranted.

Full Text

The Full Text of this article is available as a PDF (259.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam D., de Visser I., Koeppe P. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination. Antimicrob Agents Chemother. 1982 Sep;22(3):353–357. doi: 10.1128/aac.22.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes P. F., Barrows S. A. Tuberculosis in the 1990s. Ann Intern Med. 1993 Sep 1;119(5):400–410. doi: 10.7326/0003-4819-119-5-199309010-00009. [DOI] [PubMed] [Google Scholar]
  3. Bush K. Characterization of beta-lactamases. Antimicrob Agents Chemother. 1989 Mar;33(3):259–263. doi: 10.1128/aac.33.3.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bush K. Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'. Antimicrob Agents Chemother. 1989 Mar;33(3):264–270. doi: 10.1128/aac.33.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Casal M., Rodriguez F., Benavente M., Luna M. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin. Eur J Clin Microbiol. 1986 Aug;5(4):453–454. doi: 10.1007/BF02075706. [DOI] [PubMed] [Google Scholar]
  6. Chambers H. F., Hartman B. J., Tomasz A. Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin. J Clin Invest. 1985 Jul;76(1):325–331. doi: 10.1172/JCI111965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cynamon M. H., Palmer G. S. In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1983 Sep;24(3):429–431. doi: 10.1128/aac.24.3.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fattorini L., Orefici G., Jin S. H., Scardaci G., Amicosante G., Franceschini N., Chopra I. Resistance to beta-lactams in Mycobacterium fortuitum. Antimicrob Agents Chemother. 1992 May;36(5):1068–1072. doi: 10.1128/aac.36.5.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Finch R. Beta-lactam antibiotics and mycobacteria. J Antimicrob Chemother. 1986 Jul;18(1):6–8. doi: 10.1093/jac/18.1.6. [DOI] [PubMed] [Google Scholar]
  10. Foulds G., Stankewich J. P., Marshall D. C., O'Brien M. M., Hayes S. L., Weidler D. J., McMahon F. G. Pharmacokinetics of sulbactam in humans. Antimicrob Agents Chemother. 1983 May;23(5):692–699. doi: 10.1128/aac.23.5.692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Frieden T. R., Sterling T., Pablos-Mendez A., Kilburn J. O., Cauthen G. M., Dooley S. W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993 Feb 25;328(8):521–526. doi: 10.1056/NEJM199302253280801. [DOI] [PubMed] [Google Scholar]
  12. Ghuysen J. M. Serine beta-lactamases and penicillin-binding proteins. Annu Rev Microbiol. 1991;45:37–67. doi: 10.1146/annurev.mi.45.100191.000345. [DOI] [PubMed] [Google Scholar]
  13. Iseman M. D. Evolution of drug-resistant tuberculosis: a tale of two species. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2428–2429. doi: 10.1073/pnas.91.7.2428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jarlier V., Gutmann L., Nikaido H. Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae. Antimicrob Agents Chemother. 1991 Sep;35(9):1937–1939. doi: 10.1128/aac.35.9.1937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jarlier V., Nikaido H. Permeability barrier to hydrophilic solutes in Mycobacterium chelonei. J Bacteriol. 1990 Mar;172(3):1418–1423. doi: 10.1128/jb.172.3.1418-1423.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. KASIK J. E. THE NATURE OF MYCOBACTERIAL PENICILLINASE. Am Rev Respir Dis. 1965 Jan;91:117–119. doi: 10.1164/arrd.1965.91.1.117. [DOI] [PubMed] [Google Scholar]
  17. Kasik J. E., Weber M., Freehill P. J. The effect of the penicillinase-resistant penicillins and other chemotherapeutic substances on the penicillinase of the R1Rv strain of Mycobacterium tuberculosis. Am Rev Respir Dis. 1967 Jan;95(1):12–19. doi: 10.1164/arrd.1967.95.1.12. [DOI] [PubMed] [Google Scholar]
  18. Kasik J. E., Weber M., Winberg E., Barclay W. R. The synergistic effect of dicloxacillin and penicillin G on murine tuberculosis. Am Rev Respir Dis. 1966 Aug;94(2):260–261. doi: 10.1164/arrd.1966.94.2.260. [DOI] [PubMed] [Google Scholar]
  19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  20. Laskey R. A., Mills A. D. Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem. 1975 Aug 15;56(2):335–341. doi: 10.1111/j.1432-1033.1975.tb02238.x. [DOI] [PubMed] [Google Scholar]
  21. Mizuguchi Y., Ogawa M., Udou T. Morphological changes induced by beta-lactam antibiotics in Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother. 1985 Apr;27(4):541–547. doi: 10.1128/aac.27.4.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother. 1989 Nov;33(11):1831–1836. doi: 10.1128/aac.33.11.1831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nikaido H., Rosenberg E. Y., Foulds J. Porin channels in Escherichia coli: studies with beta-lactams in intact cells. J Bacteriol. 1983 Jan;153(1):232–240. doi: 10.1128/jb.153.1.232-240.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sorg T. B., Cynamon M. H. Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis. J Antimicrob Chemother. 1987 Jan;19(1):59–64. doi: 10.1093/jac/19.1.59. [DOI] [PubMed] [Google Scholar]
  25. Trias J., Jarlier V., Benz R. Porins in the cell wall of mycobacteria. Science. 1992 Nov 27;258(5087):1479–1481. doi: 10.1126/science.1279810. [DOI] [PubMed] [Google Scholar]
  26. Watt B., Edwards J. R., Rayner A., Grindey A. J., Harris G. In vitro activity of meropenem and imipenem against mycobacteria: development of a daily antibiotic dosing schedule. Tuber Lung Dis. 1992 Jun;73(3):134–136. doi: 10.1016/0962-8479(92)90145-A. [DOI] [PubMed] [Google Scholar]
  27. Waxman D. J., Strominger J. L. Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics. Annu Rev Biochem. 1983;52:825–869. doi: 10.1146/annurev.bi.52.070183.004141. [DOI] [PubMed] [Google Scholar]
  28. Wong C. S., Palmer G. S., Cynamon M. H. In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acid. J Antimicrob Chemother. 1988 Dec;22(6):863–866. doi: 10.1093/jac/22.6.863. [DOI] [PubMed] [Google Scholar]
  29. Yajko D. M., Nassos P. S., Sanders C. A., Hadley W. K. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774. Am Rev Respir Dis. 1989 Nov;140(5):1198–1203. doi: 10.1164/ajrccm/140.5.1198. [DOI] [PubMed] [Google Scholar]
  30. Zhang Y., Steingrube V. A., Wallace R. J., Jr beta-Lactamase inhibitors and the inducibility of the beta-lactamase of Mycobacterium tuberculosis. Am Rev Respir Dis. 1992 Mar;145(3):657–660. doi: 10.1164/ajrccm/145.3.657. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES